Skip to main content
Caplight Logo









GlucoSet

GlucoSet

Private
TrondheimHealthcare & Life Scienceshttps://www.glucoset.com/

Last Round

Series A

Jul 7, 2023

Total Funding Raised

$5.78M

Company Overview

GlucoSet is a medical technology company developing a novel continuous glucose monitor for critical care patients.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Sensors

Business Model

B2B

Customer Profile

Hardware + Subscription, Hardware Sales

AI Layer

Non-AI

Keywords

continuous glucose monitoringCGMintravascular sensorintensive care monitoringmedical devicecatheter-based biosensorglycemic controlcritical care technologyicu monitoringdisposable medical sensorblood glucose monitorsmart glucose sensormedtechpatient monitoring systemarterial line integration

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

GlucoSet Comparables

Compare GlucoSet with similar companies based on industry and business-model similarity.

GlucoSet comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Flowsion A/S
87%
Admetsys Corporation
81%
Getinge AB
81%

GlucoSet Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJul 7, 2023
GrantJan 1, 2023
GrantDec 19, 2022
GrantNov 5, 2021

Key People

Founding team and executive leadership

Nicolas Elvemo

CEO

Executive Team

Lukas Scherer

Chief Technology Officer

Executive Team

GlucoSet Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 5, 2021

    $100K raised from Diabetes Center Berne

GlucoSet Filings

Explore SEC and related filing metadata, where available.

GlucoSet filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about GlucoSet's valuation, stock price, and market status.

Is GlucoSet a public or private company?

GlucoSet is a private company.

What is the current stock price of GlucoSet?

GlucoSet is a private company with no public stock price. No recent secondary market data is available.

How much is GlucoSet worth (valuation)?

Valuation information for GlucoSet is not publicly available.

Can I buy GlucoSet stock?

GlucoSet shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was GlucoSet's last funding round?

GlucoSet's most recent funding round was Series A on July 7, 2023.

Who are the main investors in GlucoSet?

Key investors in GlucoSet include Norsk Innovasjonskapital IV, Credit Suisse Group AG.

Will GlucoSet IPO soon?

No public IPO plans have been announced for GlucoSet.

How can I track GlucoSet secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor GlucoSet's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersTrondheim
Employee Range12
Year Founded2011
Last FundingJul 7, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?